Announcements
- Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
- Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
- Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
- Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
- Assembly Biosciences Announces Effective Date of Reverse Stock Split
- Assembly Biosciences Provides Anticipated Development Milestones for 2024
- Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
- Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
- Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer
More ▼
Key statistics
On Thursday, Assembly Biosciences Inc (V7B:DEU) closed at 14.45, 110.15% above the 52 week low of 6.88 set on Nov 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.20 |
---|---|
High | 15.10 |
Low | 13.50 |
Bid | 13.85 |
Offer | 14.50 |
Previous close | 14.20 |
Average volume | 3.94k |
---|---|
Shares outstanding | 5.51m |
Free float | 3.69m |
P/E (TTM) | -- |
Market cap | 83.25m USD |
EPS (TTM) | -11.22 USD |
Data delayed at least 15 minutes, as of Jun 06 2024.
More ▼